Valuation: QHSLab, Inc.

Market Cap 3.98M 3.48M 3.2M 2.98M 5.66M 379M 5.74M 38.42M 14.94M 186M 14.95M 14.63M 642M P/E 2024
-8.27x
P/E 2025 30.3x
Enterprise Value 3.64M 3.18M 2.92M 2.73M 5.17M 347M 5.25M 35.11M 13.65M 170M 13.66M 13.37M 587M EV / Sales 2024
1.97x
EV / Sales 2025 2.41x
Free-Float
51.27%
Yield 2024 *
-
Yield 2025 -
1 day-11.67%
1 month-41.18%
3 months-60.74%
6 months-70.55%
Current year-56.26%
1 month 0.25
Extreme 0.2457
0.43
Current year 0.25
Extreme 0.2457
1.14
1 year 0.08
Extreme 0.08
1.14
3 years 0.02
Extreme 0.0155
1.14
5 years 0.02
Extreme 0.0155
1.14
10 years 0
Extreme 0.005
1.14
Manager TitleAgeSince
Chief Executive Officer 49 2016-06-27
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2024-05-01
Director TitleAgeSince
Chairman 49 2016-06-27
Date Insider Type Main position Quantity % Market Cap.
12-30Others

Chief Executive Officer

2,644,424 100.0000%
12-30Others

Chief Executive Officer

1,080,092 100.0000%
12-30Conversion

Chief Executive Officer

213,075 1.8887%
Change 5-day change 1-year change 3-year change Capi.($)
-11.67%-.--%+26.19%+79.05% 3.98M
+1.97%+2.03%+21.92%+0.83% 195B
+5.87%+5.27%-21.76%+26.78% 151B
+2.17%+0.89%-2.59%-16.42% 140B
+4.83%+2.06%-56.73%-15.69% 67.09B
+2.59%+3.95%+22.89%+3.15% 54.34B
+0.03%+2.19%-25.48%-31.00% 44.64B
-2.02%-3.91%+7.67%+9.53% 36.91B
+0.31%+1.30%+8.30%+43.25% 37.24B
+1.09%-0.30%-13.81%-18.74% 29.82B
Average +0.52%-0.18%-3.34%+8.07% 75.55B
Weighted average by Cap. +2.66%+3.26%-3.84%+1.38%

Financials

2024 2025
Net sales 2.13M 1.86M 1.71M 1.6M 3.03M 203M 3.07M 20.56M 7.99M 99.78M 8M 7.83M 344M 2.69M 2.35M 2.16M 2.02M 3.82M 256M 3.88M 25.96M 10.09M 126M 10.1M 9.89M 434M
Net income -259K -227K -208K -194K -368K -24.68M -374K -2.5M -972K -12.13M -973K -952K -41.81M 457K 400K 367K 343K 650K 43.55M 660K 4.41M 1.72M 21.41M 1.72M 1.68M 73.77M
Net Debt 1.58M 1.38M 1.27M 1.18M 2.24M 150M 2.28M 15.23M 5.92M 73.89M 5.93M 5.8M 255M -343K -300K -276K -257K -488K -32.69M -495K -3.31M -1.29M -16.07M -1.29M -1.26M -55.36M
Logo QHSLab, Inc.
QHSLab, Inc. is a medical device technology and software as a service (SaaS) company focused on primary care physicians (PCPs) and other healthcare providers to offer tools to evaluate and treat chronic diseases as well as provide preventive care through reimbursable procedures. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. It also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The Company sells allergy diagnostic-related products and immunotherapy treatments to physicians.
Employees
12
Date Price Change Volume
26-06-25 US$0.2650 -11.67% 27,147
  1. Stock Market
  2. Stocks
  3. USAQ Stock